SA, B., J, H. L., AM, K., C, S., DM, S., M, A., . . . AT, T. (2023). Long-Term Follow-up of Parenteral Bevacizumab In Patients with Recurrent Respiratory Papillomatosis. The Laryngoscope, 133(10), 2725. https://doi.org/10.1002/lary.30617
Chicago Style (17th ed.) CitationSA, Ballestas, et al. "Long-Term Follow-up of Parenteral Bevacizumab In Patients with Recurrent Respiratory Papillomatosis." The Laryngoscope 133, no. 10 (2023): 2725. https://doi.org/10.1002/lary.30617.
MLA (9th ed.) CitationSA, Ballestas, et al. "Long-Term Follow-up of Parenteral Bevacizumab In Patients with Recurrent Respiratory Papillomatosis." The Laryngoscope, vol. 133, no. 10, 2023, p. 2725, https://doi.org/10.1002/lary.30617.
Warning: These citations may not always be 100% accurate.